


On March 8, 2023, the National Medical Products Administration (NMPA) of China conditionally approved Gumarontinib fo...
-
PNAS|Cryo-EM Structures Reveal How GnRH Activates Its Receptor, Opening Pathways for New Therapies
In a study published in PNAS, a team led by DUAN Jia and XU Huaqiang (H. Eric XU) from the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences, reported high...
-
Researchers Disrupt cGAS-DNA Phase Separation by De Novo Design of Allosteric Inhibitors: A Potential Therapeutic Strategy
In a study published in Nature Communications, a research team led by XU Yechun from the Shanghai Institute of Materia Medica (SIMM) of the Chinese Academy of Sciences (CAS) rep...
-
Researchers Develop Tracheal Targeted Nanogrid Drug Delivery Systems Visualized by Three-dimensional Pathological Mapping
In a study published in ACS Nano, a research team led by YIN Xianzhen from the Lingang Laboratory and ZHANG Jiwen from the Shanghai Institute of Materia Medica (SIMM) of the Chi...